Let me just add. The Team at CytoDyn has my full b

Let me just add. The Team at CytoDyn has my full backing and confidence. And I think Dr J has a great strategy that will soon liberate the stock price.

Some on the board have asked who would benefit from manipulating the price of our great company and the answer is simpler than you think:
(1) Any entity that can make money manipulating the price (for instance, a hedge fund) (2) Any entity that might benefit by denying funding to a small start up biotech with a wonderful drug that might cut into their market share.

Is this the motive? I don't know. But I do know the price is being manipulated and in effect by denying funding or making it much harder to get funding you delay clinical trials (allowing you more time to compete with drugs you have in the pipeline) or by denying funding through the stock market some clinical trials don't get funded at all.

It’s wrong, plain and simple.

On principle, this is exactly why I am against various entities (third parties perhaps working on behalf of those with a vested interest to deny funding) and day traders borrowing shares they don't own to sell biotech companies (and I'm not talking about warrants here). It doesn't provide liquidity; it denies liquidity to the biotech startup company that needs it in order to create wonderful treatments. If it were potato chips I wouldn't care, but people need these drugs.

Luckily, we have an antidote to this kind of mischief in the marketplace:
Dr J
Foundations,
and other Sources of financing.

Folks, we are at First and Goal, and our company will be scoring soon